|
Intervention cost
|
Average SP price per administrationa
|
0.2 (0.16–0.25)
|
|
Average AL price per administrationa
|
2.39 (1.71–3.06)
|
|
Average RDT price per administrationa
|
0.81 (0.58–0.90)
|
|
HCW time cost per dose of IPTp-SP
|
0.59 (0.33–0.91)
|
|
HCW time cost per administration of ISTp-AL if screened negative
|
0.64 (0.36–1.00)
|
|
HCW time cost per administration of ISTp-AL if screened positive
|
0.84 (0.47–1.31)
|
|
Total cost per administration of IPTp-SP (HCW time and commodity cost)
|
0.79 (0.53–1.12)
|
|
Total cost per administration of ISTp-AL if screened negative (HCW time and commodity cost)
|
1.45 (1.12–1.85)
|
|
Total cost per administration of ISTp-AL if screened positive (HCW time and commodity cost)
|
4.06 (3.29–4.97)
|
|
Health provider costs excluding medical supplies
|
Cost per OP visit
|
11.78 (9.18–14.68)
|
|
Cost per IP day adult
|
35.27 (19.99–55.07)
|
|
Cost per paediatric IP day (nursery)
|
63.51 (36.3–99.27)
|
|
Health provider costs of consequences
|
Total average short term cost per LBW baby
|
40.93 (19.52–71.19)
|
|
Total average cost per moderate/severe anaemia case
|
10.15 (6.76–15.17)
|
|
Total average cost per clinical malaria case
|
13.71 (6.12–24.65)
|
